Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

RespireRx Pharma

RSPIOTCEM

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.00110

At close: Jan 27, 3:01 PM EDT

$0.00070

-0.00040-36.36%

After Hours: Jan 17, 4:00 PM EDT

RespireRx Pharma (RSPI) Forecast

News

Earnings RespireRx Pharma (RSPI) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for RespireRx Pharma (OTC:RSPI) Stock

RespireRx Pharma Stock (OTC: RSPI)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, August 09, 2023

RespireRx Transferes Its Pharmaceutical Cannabinoid Program To ResolutionRx
Vuk Zdinjak

Thursday, November 17, 2022

RespireRx Signs LOI With Australian CRO For Dronabinol Development For Obstructive Sleep Apnea
Vuk Zdinjak

Wednesday, April 06, 2022

Sleep Apnea—A Plague for America with More Help on the Way
Zacks Small Cap Research

Thursday, March 24, 2022

RespireRx Pharmaceuticals Files Patent: Claims To Improve Solubility & Bioavailability Of Cannabinoids
Vuk Zdinjak

Tuesday, December 14, 2021

Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday
Jad Malaeb - Sponsored

Tuesday, August 04, 2020

Cannabis Movers & Shakers: MPXI, Benzinga, RespireRx, MedMen, Medipharm
Jelena Martinovic

Tuesday, March 24, 2020

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights

Thursday, February 06, 2020

Stocks That Hit 52-Week Lows On Thursday
Lisa Levin

Wednesday, December 11, 2019

Stocks That Hit 52-Week Lows On Wednesday
Lisa Levin

Friday, December 06, 2019

Stocks That Hit 52-Week Lows On Friday
Lisa Levin

Friday, November 15, 2019

Stocks That Hit 52-Week Lows On Friday
Lisa Levin

Wednesday, July 13, 2016

RespireRx Releases Slide Presentation for Cantor Healthcare Conf
Benzinga

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved